XtalPi Revenue and Competitors

Claim your profile

Boston, MA USA

Location

#653

Growjo Ranking

AI

Industry

Estimated Revenue & Valuation

  • XtalPi's estimated annual revenue is currently $15.5M per year.(i)
  • XtalPi's estimated revenue per employee is $140,000
  • XtalPi's total funding is $786.4M.
  • XtalPi's current valuation is $2B.

Employee Data

  • XtalPi has 111 Employees.(i)
  • XtalPi grew their employee count by 37% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.7M53N/AN/AN/A
#2
$1.1M13N/AN/AN/A
#3
$1.1M13N/AN/AN/A
#4
$1.1M1318%N/AN/A
#5
$1.6M19N/AN/AN/A
#6
$1190M64273%$31MN/A
#7
$1.5M18N/AN/AN/A
#8
$1.5M18-18%N/AN/A
#9
$0.9M11N/AN/AN/A
#10
$11.1M79N/AN/AN/A

XtalPi is a pharmaceutical technology company that is reinventing the industry's approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.   Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies. Its recently completed Series B funding round through Sequoia China, Tencent, and Google makes XtalPi one of the best-funded AI companies in biotechnology.

keywords:N/A

$786.4M

Total Funding

111

Number of Employees

$15.5M

Revenue (est)

37%

Employee Growth %

$2B

Valuation

N/A

Accelerator

XtalPi News

10/24/2018 - XtalPi announces the closing of $46 million Series B-1 ...

CAMBRIDGE, Mass., Oct. 24, 2018 /PRNewswire/ -- XtalPi Inc., a computation-driven biotech startup integrating quantum physics, artificial ...

10/29/2018 - Biotech startup XtalPi closes $46 million in Series B-1 ...

Computation-driven biotech startup XtalPi continues to reinvent the pharmaceutical industry's approach to drug research and development with ...

08/26/2019 - Drug Designing Tools Market 2019 Business Scenario ...

Drug Designing Tools Market 2019 Business Scenario – BioSolveIT, ChemAxon, XtalPi, Agilent Technologies, Schrodinger, Biovia Corporation ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$36.1M1111%N/A
#2
$15.5M11131%$129.6M
#3
N/A11113%N/A
#4
$8.5M11218%$305.9M
#5
$19.5M11211%N/A